Ocugen’s OCU410ST Granted Rare Pediatric Disease Designation for ABCA4-Associated Retinopathies奥库根公司的OCU410ST获得ABCA4相关视网膜病的罕见儿科疾病认定May 28, 20252025年5月28日The U.S. Food and Drug Administration (FDA) has...
Source LinkOcugen’s OCU410ST Granted Rare Pediatric Disease Designation for ABCA4-Associated Retinopathies奥库根公司的OCU410ST获得ABCA4相关视网膜病的罕见儿科疾病认定May 28, 20252025年5月28日The U.S. Food and Drug Administration (FDA) has...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.